Additional file 1 of Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

MLA

Sojung Park, et al. Additional File 1 of Comparison of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Patients with Lung Adenocarcinoma Harboring Different Epidermal Growth Factor Receptor Mutation Types. Jan. 2021. EBSCOhost, https://doi.org/10.6084/m9.figshare.13559869.

APA

Sojung Park, Lee, S. Y., Dojin Kim, Sim, Y. S., Jeong-Seon Ryu, Juwhan Choi, Lee, S. H., Ryu, Y. J., Lee, J. H., & Chang, J. H. (2021). Additional file 1 of Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types. https://doi.org/10.6084/m9.figshare.13559869

Chicago

Sojung Park, Sung Yong Lee, Dojin Kim, Yun Su Sim, Jeong-Seon Ryu, Juwhan Choi, Su Hwan Lee, Yon Ju Ryu, Jin Hwa Lee, and Jung Hyun Chang. 2021. “Additional File 1 of Comparison of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Patients with Lung Adenocarcinoma Harboring Different Epidermal Growth Factor Receptor Mutation Types,” January. doi:10.6084/m9.figshare.13559869.